This review summarizes the current landscape of ADC development, focusing on target selection and adverse impacts. It will guide future research to optimize the efficacy and safety of ADCs. ADCs are a ...
HEIDELBERG, BADEN-WüRTTEMBERG, GERMANY, February 17, 2026 /EINPresswire.com/ — Cytion, a trusted provider of authenticated, contamination-free human cell lines ...
CAMBRIDGE, Mass., April 22, 2026 — Insilico Medicine (“Insilico”, 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, recently published a comprehensive ...
Insilico Medicine, a clinical-stage biotechnology company powered by generative artificial intelligence (AI), today announced advancements to its unified AI framework for drug target discovery, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results